Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development.

Autor: Bialer M; Institute for Drug Research, School of Pharmacy, Faculty of Medicine and David R. Bloom Center for Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel., Johannessen SI; National Center for Epilepsy, Sandvika, Norway.; Member of European Reference Network EpiCARE, Oslo University Hospital, Oslo, Norway.; Section for Clinical Pharmacology, Department of Pharmacology, Oslo University Hospital, Oslo, Norway., Koepp MJ; Department of Clinical and Experimental Epilepsy, University College London (UCL), Queen Square Institute of Neurology, London, UK., Perucca E; Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Perucca P; Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.; Bladin-Berkovic Comprehensive Epilepsy Program, Department of Neurology, Austin Health, Melbourne, Victoria, Australia.; Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia., Tomson T; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden., White HS; Center for Epilepsy Drug Discovery, Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA.

Publikováno v: Epilepsia [Epilepsia] 2024 Oct; Vol. 65 (10), pp. 2831-2857. Date of Electronic Publication: 2024 Jul 15.

Pharmacokinetic Variability of Rufinamide and Stiripentol in Children With Refractory Epilepsy: A Retrospective Study of Therapeutic Drug Monitoring From the National Epilepsy Centers in Denmark and Norway.

Autor: Heger K; Department of Pharmacy, Oslo Metropolitan University, Oslo, Norway., Burns ML; Department of Pharmacology, Oslo University Hospital, Oslo, Norway., Nikanorova M; The National Center for Epilepsy, Member of the ERN EpiCARE, Oslo University Hospital, Oslo, Norway; and., Johannessen SI; Department of Pharmacology, Oslo University Hospital, Oslo, Norway.; The Danish Epilepsy Center Filadelfia, Dianalund, Denmark., Johannessen Landmark C; Department of Pharmacy, Oslo Metropolitan University, Oslo, Norway.; Department of Pharmacology, Oslo University Hospital, Oslo, Norway.; The Danish Epilepsy Center Filadelfia, Dianalund, Denmark.

Publikováno v: Therapeutic drug monitoring [Ther Drug Monit] 2024 Oct 01; Vol. 46 (5), pp. 664-671. Date of Electronic Publication: 2024 May 15.

Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring.

Autor: Johannessen Landmark C; Department of Pharmacy, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.; The National Center for Epilepsy, Sandvika, Member of the ERN EpiCare, Oslo University Hospital, Oslo, Norway.; Section for Clinical Pharmacology, Department of Pharmacology, Oslo University Hospital, Oslo, Norway., Eyal S; Institute for Drug Research, Department of Pharmacy, Faculty of Medicine, Hebrew University, Jerusalem, Israel., Burns ML; Section for Clinical Pharmacology, Department of Pharmacology, Oslo University Hospital, Oslo, Norway., Franco V; Department of Internal Medicine and Therapeutics, Clinical, and Experimental Pharmacology Unit, University of Pavia, Pavia, Italy.; IRCCS Mondino Foundation, Pavia, Italy., Johannessen SI; The National Center for Epilepsy, Sandvika, Member of the ERN EpiCare, Oslo University Hospital, Oslo, Norway.; Section for Clinical Pharmacology, Department of Pharmacology, Oslo University Hospital, Oslo, Norway.

Publikováno v: Epileptic disorders : international epilepsy journal with videotape [Epileptic Disord] 2023 Aug; Vol. 25 (4), pp. 454-471. Date of Electronic Publication: 2023 Jun 01.

Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): I. Drugs in preclinical and early clinical development.

Autor: Bialer M; Institute for Drug Research, School of Pharmacy, Faculty of Medicine and David R. Bloom Center for Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel., Johannessen SI; National Center for Epilepsy, Sandvika, Norway.; Department of Pharmacology, Oslo University Hospital, Oslo, Norway., Koepp MJ; Department of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London, UK., Levy RH; Department of Pharmaceutics and Neurological Surgery, University of Washington, Seattle, Washington, USA., Perucca E; Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Perucca P; Department of Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Bladin-Berkovic Comprehensive Epilepsy Program, Department of Neurology, Austin Health, Melbourne, Victoria, Australia.; Department of Neurology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Neurology, Alfred Health, Melbourne, Victoria, Australia., Tomson T; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden., White HS; Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA.

Publikováno v: Epilepsia [Epilepsia] 2022 Nov; Vol. 63 (11), pp. 2865-2882. Date of Electronic Publication: 2022 Aug 09.

The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results.

Autor: Johannessen Landmark C; Program for Pharmacy, Department of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.; National Center for Epilepsy, Oslo University Hospital, Oslo, Norway.; Section for Clinical Pharmacology, Department of Pharmacology, Oslo University Hospital, Oslo, Norway., Potschka H; Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig Maximilian University of Munich, Munich, Germany., Auvin S; Pediatric Neurology Department, Robert Debré Hospital, Public Hospital Network of Paris, Paris, France.; Mixed Unit of Research NeuroDiderot U1141, University of Paris, Paris, France., Wilmshurst JM; Paediatric Neurology Department, Red Cross War Memorial Children's Hospital, Neuroscience Institute, University of Cape Town, Cape Town, South Africa., Johannessen SI; National Center for Epilepsy, Oslo University Hospital, Oslo, Norway.; Section for Clinical Pharmacology, Department of Pharmacology, Oslo University Hospital, Oslo, Norway., Kasteleijn-Nolst Trenité D; Department of Neurosurgery and Epilepsy, University Medical Center Utrecht, Utrecht, the Netherlands., Wirrell EC; Divisions of Child and Adolescent Neurology and Epilepsy, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Epilepsia [Epilepsia] 2021 Apr; Vol. 62 (4), pp. 857-873. Date of Electronic Publication: 2021 Feb 27.